These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31480430)

  • 1. Identifying Methylation Pattern and Genes Associated with Breast Cancer Subtypes.
    Chen L; Zeng T; Pan X; Zhang YH; Huang T; Cai YD
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation epigenotypes in breast cancer molecular subtypes.
    Bediaga NG; Acha-Sagredo A; Guerra I; Viguri A; Albaina C; Ruiz Diaz I; Rezola R; Alberdi MJ; Dopazo J; Montaner D; Renobales M; Fernández AF; Field JK; Fraga MF; Liloglou T; de Pancorbo MM
    Breast Cancer Res; 2010; 12(5):R77. PubMed ID: 20920229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
    Győrffy B; Bottai G; Fleischer T; Munkácsy G; Budczies J; Paladini L; Børresen-Dale AL; Kristensen VN; Santarpia L
    Int J Cancer; 2016 Jan; 138(1):87-97. PubMed ID: 26174627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
    Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
    Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deconvolution of DNA methylation identifies differentially methylated gene regions on 1p36 across breast cancer subtypes.
    Titus AJ; Way GP; Johnson KC; Christensen BC
    Sci Rep; 2017 Sep; 7(1):11594. PubMed ID: 28912426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.
    Li Y; Li S; Chen J; Shao T; Jiang C; Wang Y; Chen H; Xu J; Li X
    Hum Mol Genet; 2014 Oct; 23(20):5378-93. PubMed ID: 24871326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer.
    Fernandez-Jimenez N; Sklias A; Ecsedi S; Cahais V; Degli-Esposti D; Jay A; Ancey PB; Woo HD; Hernandez-Vargas H; Herceg Z
    Epigenetics; 2017; 12(11):964-972. PubMed ID: 29099283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the effect of DNA methylation on gene expression in cancer cells.
    Lee CJ; Evans J; Kim K; Chae H; Kim S
    Methods Mol Biol; 2014; 1101():161-78. PubMed ID: 24233782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin.
    Lee SE; Kim SJ; Yoon HJ; Yu SY; Yang H; Jeong SI; Hwang SY; Park CS; Park YS
    J Pineal Res; 2013 Jan; 54(1):80-8. PubMed ID: 22856590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
    Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
    BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A seven-gene CpG-island methylation panel predicts breast cancer progression.
    Li Y; Melnikov AA; Levenson V; Guerra E; Simeone P; Alberti S; Deng Y
    BMC Cancer; 2015 May; 15():417. PubMed ID: 25986046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel subtype classification and risk of breast cancer by histone modification profiling.
    Chen X; Hu H; He L; Yu X; Liu X; Zhong R; Shu M
    Breast Cancer Res Treat; 2016 Jun; 157(2):267-279. PubMed ID: 27178334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for Analyzing Epigenetic Regulation Mechanisms in Breast Cancer.
    Pagolu SLB; Parekh N
    Methods Mol Biol; 2024; 2812():275-306. PubMed ID: 39068369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying subtype-specific associations between gene expression and DNA methylation profiles in breast cancer.
    Lee G; Bang L; Kim SY; Kim D; Sohn KA
    BMC Med Genomics; 2017 May; 10(Suppl 1):28. PubMed ID: 28589855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
    Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
    Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the breast cancer methylome using formalin-fixed paraffin-embedded tumour.
    Wong EM; Joo JE; McLean CA; Baglietto L; English DR; Severi G; Wu HC; Terry MB; Hopper JL; Milne RL; Giles GG; Southey MC
    Breast Cancer Res Treat; 2016 Nov; 160(1):173-180. PubMed ID: 27604360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.
    Acun T; Doberstein N; Habermann JK; Gemoll T; Thorns C; Oztas E; Ried T
    OMICS; 2017 May; 21(5):257-265. PubMed ID: 28481734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.